Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite

New Trends in Dual 5-LOX / COX Inhibition

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 941-962

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

By Ballinger A.   Smith G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 31-40

Informa Healthcare

Access to resources Recommend Favorite

COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2213-2219

Bentham Science Publishers

Access to resources Recommend Favorite